Tiotropium bromide: A new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease

Tiotropium offers several advantages over ipratropium in the management of COPD. Long-term (>1 year) studies are necessary to determine the impact of tiotropium on disease progression and life expectancy.